Endometrial carcinoma (EC) is a group of endometrial epithelial malignancies, most of
which are adenocarcinomas and occur in perimenopausal and postmenopausal women. It …

Although pituitary neuroendocrine tumors (PitNETs) are usually benign, some are highly
invasive and recurrent. Recurrent PitNETs are often treatment‐resistant and there is …

Purpose The aim of this study is to evaluate the impact of the oestrogen receptor (ER) profile
on oncologic outcomes in the new endometrial cancer (EC) risk classification. Methods …

CD163 is one of the scavenger receptors expressed on macrophages. However, several
immunohistochemical studies have demonstrated that CD163 is also detected on cancer …

SUMMARY OBJECTIVE: Our goal was to contrast the prognoses of patients with
endometrial cancer who had adenomyosis against those that did not. METHODS: All …

Purpose To investigate prognostic factors affecting cancer-specific survival (CSS) and to
analyze the survival outcomes of patients with undifferentiated and dedifferentiated …

Aim We aimed to clarify the clinical value of P53 index in patients with early low‐risk
endometrial cancer (EC) and find an optimal cut‐off value of P53 index for predicting the …

Background & Objective: Endometrial Carcinoma (EC) is the most common gynecological
cancer with a global incidence of 23.2 per 1 lakh population. Histological subclassification of …

目的: 研究孕激素受体(Progesterone receptor, PR), 皮肤桥蛋白(Dermatopontin, DPT)
和转化生长因子-β1 (Transfermation growth factor β1, TGF-β1) 在子宫内膜癌中的表达及其对 …

Background: Endometrial cancer (EC) tissues express CYP7B1, but its association with
prognosis needs to be investigated. Methods: Immunohistochemistry and image analysis …